首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2242878篇
  免费   363008篇
  国内免费   43966篇
耳鼻咽喉   29774篇
儿科学   66504篇
妇产科学   58749篇
基础医学   343745篇
口腔科学   59332篇
临床医学   228607篇
内科学   469688篇
皮肤病学   49043篇
神经病学   184728篇
特种医学   90971篇
外国民族医学   432篇
外科学   349263篇
综合类   98677篇
现状与发展   4篇
一般理论   676篇
预防医学   195179篇
眼科学   61959篇
药学   196286篇
  9篇
中国医学   50193篇
肿瘤学   116033篇
  2019年   26872篇
  2018年   33319篇
  2017年   29905篇
  2016年   31175篇
  2015年   33532篇
  2014年   41737篇
  2013年   56490篇
  2012年   67892篇
  2011年   73004篇
  2010年   52089篇
  2009年   56758篇
  2008年   66861篇
  2007年   67853篇
  2006年   68224篇
  2005年   66429篇
  2004年   66247篇
  2003年   63737篇
  2002年   61203篇
  2001年   101146篇
  2000年   99933篇
  1999年   88675篇
  1998年   34592篇
  1997年   31545篇
  1996年   32230篇
  1995年   32025篇
  1994年   30523篇
  1993年   28423篇
  1992年   74493篇
  1991年   72520篇
  1990年   69796篇
  1989年   66868篇
  1988年   62589篇
  1987年   61257篇
  1986年   57909篇
  1985年   55574篇
  1984年   42805篇
  1983年   36974篇
  1982年   25617篇
  1981年   23425篇
  1980年   22144篇
  1979年   40863篇
  1978年   30308篇
  1977年   26325篇
  1976年   24196篇
  1975年   25283篇
  1974年   29854篇
  1973年   28507篇
  1972年   26958篇
  1971年   24591篇
  1970年   22964篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
[目的] 系统评价八段锦治疗神经根型颈椎病的临床疗效。[方法] 计算机检索中国知网数据库(CNKI)、维普资讯中文科技期刊数据库(VIP)、万方数据库(Wan-fang)、中国生物医学文献数据库(SinoMed)、Web of science、Clinical Trials gov、Pubmed、EMBASE、CENTRAL、Cochrane Library,查找出八段锦治疗神经根型颈椎病的随机对照试验(RCT),检索时限均从建库至2019年7月1日。两名研究者按照纳入与排除标准独立进行文献筛选、资料提取和偏倚风险评估,应用RevMan 5.3软件对最后纳入的研究进行Meta分析。[结果] 最终纳入10个RCT,共843例患者。Meta分析结果显示:八段锦+常规治疗与常规治疗比较,其临床疗效的总有效率差异具有统计学意义[OR=4.19,95% CI(2.42,7.26),P<0.000 01];八段锦+常规治疗与常规治疗+颈部“米”字操比较,其临床疗效的总有效率差异具有统计学意义[OR=3.41,95% CI(1.56,7.46),P=0.002];八段锦+常规治疗与常规治疗比较,其疼痛视觉模拟评分法(VAS)评分差异具有统计学意义[MD=-1.90,95% CI(-1.97,-1.83),P<0.000 01]。[结论] 基于现有的研究,该系统评价显示,与常规治疗相比,八段锦+常规治疗在临床疗效总有效率、VAS评分方面有一定的治疗优势。与常规治疗+颈部“米”字操比较,八段锦+常规治疗在临床疗效的总有效率方面有一定的治疗优势。但由于纳入研究的质量不高,仍需要大样本、多中心、随机、双盲试验及试验参照CONSORT标准和STRICTA声明进行RCT研究。  相似文献   
132.
133.
A 17‐year‐old boy presented with recurring severe dermatitis of the face of 5‐months duration that resembled impetigo. He had been treated with several courses of antibiotics without improvement. Biopsy showed changes consistent with allergic contact dermatitis and patch testing later revealed sensitization to benzoyl peroxide, which the patient had been using for the treatment of acne vulgaris.  相似文献   
134.
Guidelines and consensus on the management of patients with acne aim to give evidence-based, expert-group recommendations. This review compares current guidelines and consensus articles to provide a compilation of recommendations on the treatment of acne with oral isotretinoin. Ten common, relevant, clinical questions are addressed, based on published recommendations, including the indications of isotretinoin, the proposed daily dose, the cumulative isotretinoin dose and the laboratory monitoring needed. Recommendations on special considerations are also addressed, including the timing of procedures and the question of an association of depression or inflammatory bowel disease with isotretinoin. A major limitation is the use of different classification systems for acne across guidelines. The recommended daily dose ranges from 0.3 to 0.5 mg/kg in the European guidelines to up to 1 mg/kg in the US guidelines. A specific duration of treatment of at least 6 months is only recommended in the European guidelines. All guidelines report the need of strict pregnancy prevention measures. The European, French and US guidelines recommend to monitor for symptoms of depression. Important clinical questions that are inconsistently addressed in guidelines include the age indication, the recommendation for a cumulative dose, the timing of procedures, the association of isotretinoin with IBD, the recommendation for preventing acne flares and for appropriate laboratory monitoring. These topics should be clearly included in the recommendations of guidelines as they are often raised in everyday clinical practice.  相似文献   
135.
136.
137.
Acute lung injury (ALI) caused by systemic inflammatory response remains a leading cause of morbidity and mortality in critically ill patients. Management of patients with sepsis is largely limited to supportive therapies, reflecting an incomplete understanding of the underlying pathophysiology. Furthermore, there have been limited advances in the treatments for ALI. In this study, lung function and a histological analysis were performed to evaluate the impact of transient receptor potential vanilloid‐1 receptor (TRPV1) antagonist (capsazepine; CPZ) on the lipopolysaccharide (LPS)‐induced lung injury in mice. For this, adult mice pre‐treated with CPZ or vehicle received intraperitoneal injections of LPS or saline and 24 hr after, the mice were anaesthetized, and lung mechanics was evaluated. The LPS‐challenged mice exhibited substantial mechanical impairment, characterized by increases in respiratory system resistance, respiratory system elastance, tissue damping and tissue elastance. The pre‐treatment with CPZ prevented the increase in respiratory system resistance and decreased the increase in tissue damping during endotoxemia. In addition, mice pre‐treated with CPZ had an attenuated lung injury evidenced by reduction on collapsed area of the lung parenchyma induced by LPS. This suggests that the TRPV1 antagonist capsazepine has a protective effect on lung mechanics in ALI during endotoxemia and that it may be a target for enhanced therapeutic efficacy in ALI.  相似文献   
138.
139.
140.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号